IL143783A - Intermediates for the preparation of eprosartan - Google Patents

Intermediates for the preparation of eprosartan

Info

Publication number
IL143783A
IL143783A IL14378398A IL14378398A IL143783A IL 143783 A IL143783 A IL 143783A IL 14378398 A IL14378398 A IL 14378398A IL 14378398 A IL14378398 A IL 14378398A IL 143783 A IL143783 A IL 143783A
Authority
IL
Israel
Prior art keywords
eprosartan
intermediates
preparation
Prior art date
Application number
IL14378398A
Other languages
English (en)
Other versions
IL143783A0 (en
Original Assignee
Smithkline Beecham Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Smithkline Beecham Corp filed Critical Smithkline Beecham Corp
Publication of IL143783A0 publication Critical patent/IL143783A0/xx
Publication of IL143783A publication Critical patent/IL143783A/xx

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D233/00Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D233/64Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with substituted hydrocarbon radicals attached to ring carbon atoms, e.g. histidine
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00Drugs for disorders of the urinary system
    • A61P13/12Drugs for disorders of the urinary system of the kidneys
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/04Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/10Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/12Antihypertensives
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D409/00Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/02Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
    • C07D409/06Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02PCLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00Technologies relating to chemical industry
    • Y02P20/50Improvements relating to the production of bulk chemicals
    • Y02P20/55Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups
IL14378398A 1997-02-14 1998-02-13 Intermediates for the preparation of eprosartan IL143783A (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US3819697P 1997-02-14 1997-02-14
IL13131098A IL131310A (en) 1997-02-14 1998-02-13 Process for preparing eprosartan
PCT/US1998/002411 WO1998035962A1 (en) 1997-02-14 1998-02-13 Process for preparing eprosartan

Publications (2)

Publication Number Publication Date
IL143783A0 IL143783A0 (en) 2002-04-21
IL143783A true IL143783A (en) 2005-05-17

Family

ID=21898590

Family Applications (4)

Application Number Title Priority Date Filing Date
IL14378498A IL143784A (en) 1997-02-14 1998-02-13 Intermediates for the preparation of eprosartan
IL13131098A IL131310A (en) 1997-02-14 1998-02-13 Process for preparing eprosartan
IL14378398A IL143783A (en) 1997-02-14 1998-02-13 Intermediates for the preparation of eprosartan
IL14378598A IL143785A (en) 1997-02-14 1998-02-13 Process for making aprosartan

Family Applications Before (2)

Application Number Title Priority Date Filing Date
IL14378498A IL143784A (en) 1997-02-14 1998-02-13 Intermediates for the preparation of eprosartan
IL13131098A IL131310A (en) 1997-02-14 1998-02-13 Process for preparing eprosartan

Family Applications After (1)

Application Number Title Priority Date Filing Date
IL14378598A IL143785A (en) 1997-02-14 1998-02-13 Process for making aprosartan

Country Status (41)

Country Link
US (2) US6294675B1 (xx)
EP (1) EP0973769B1 (xx)
JP (1) JP4227671B2 (xx)
KR (1) KR100551667B1 (xx)
CN (1) CN1093128C (xx)
AP (1) AP1202A (xx)
AR (1) AR011126A1 (xx)
AT (1) ATE274511T1 (xx)
AU (1) AU730162B2 (xx)
BG (1) BG63970B1 (xx)
BR (1) BRPI9808642B8 (xx)
CA (1) CA2281471C (xx)
CO (1) CO4950549A1 (xx)
CY (1) CY2551B1 (xx)
CZ (1) CZ296543B6 (xx)
DE (1) DE69825880T2 (xx)
DK (1) DK0973769T3 (xx)
DZ (1) DZ2418A1 (xx)
EA (1) EA001761B1 (xx)
EG (1) EG23780A (xx)
ES (1) ES2224358T3 (xx)
HK (1) HK1026206A1 (xx)
HU (1) HU228098B1 (xx)
ID (1) ID23155A (xx)
IL (4) IL143784A (xx)
IN (1) IN188000B (xx)
MA (1) MA24472A1 (xx)
MY (1) MY120024A (xx)
NO (1) NO317761B1 (xx)
NZ (1) NZ337182A (xx)
OA (1) OA11086A (xx)
PE (1) PE59799A1 (xx)
PL (1) PL192837B1 (xx)
PT (1) PT973769E (xx)
SA (1) SA98190146B1 (xx)
SI (1) SI0973769T1 (xx)
SK (1) SK285125B6 (xx)
TR (1) TR199901935T2 (xx)
UA (1) UA57060C2 (xx)
WO (1) WO1998035962A1 (xx)
ZA (1) ZA981208B (xx)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AR011126A1 (es) * 1997-02-14 2000-08-02 Smithkline Beecham Corp Procedimiento para preparar eprosartano y compuestos intermediarios.
US6630498B2 (en) * 1997-08-06 2003-10-07 Smithkline Beecham Corporation Eprosartan arginyl charge-neutralization-complex and a process for its preparation and formulation
NZ509378A (en) * 1998-07-20 2003-04-29 Smithkline Beecham Corp Amorphous ammonium salts of eprosartan and pharmaceuticals thereof, useful for blocking angiotensin II receptors and useful for treating hypertension, congestive heart disease and renal failure
US20060099230A1 (en) * 2004-11-10 2006-05-11 Chin-Chih Chiang Novel formulations of eprosartan with enhanced bioavailability
US20100137613A1 (en) * 2006-12-27 2010-06-03 Hetero Drugs Limited Process for eprosartan
NZ584845A (en) * 2007-10-22 2011-09-30 Orchid Res Lab Ltd Histone deacetylase inhibitors
CN101215284B (zh) * 2007-12-31 2010-10-13 浙江华海药业股份有限公司 一种改进的依普罗沙坦的制备方法
WO2011004384A2 (en) 2009-06-05 2011-01-13 Glochem Industries Limited Process for the preparation of eprosartan
CN102584709B (zh) * 2011-12-19 2016-08-17 浙江华海药业股份有限公司 一种改进的依普罗沙坦中间体芳基咪唑醛的制备工艺
CN103288742A (zh) * 2013-06-04 2013-09-11 四川百利药业有限责任公司 一种高纯度英加韦林原料的制备方法

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE250587T1 (de) * 1989-06-14 2003-10-15 Smithkline Beecham Corp Imidazoalkensäure
US5418250A (en) * 1989-06-14 1995-05-23 Smithkline Beecham Corporation Imidazolyl-alkenoic acids useful as angiotensin II receptor antagonists
US5185351A (en) * 1989-06-14 1993-02-09 Smithkline Beecham Corporation Imidazolyl-alkenoic acids useful as angiotensin II receptor antagonists
NZ239161A (en) * 1990-07-31 1994-01-26 Smithkline Beecham Corp Substituted [1h-imidazol-5-yl] alkanoic acid derivatives; medicaments,
AU9137791A (en) * 1990-12-14 1992-07-08 Smithkline Beecham Corporation Imidazolyl-alkenoic acids
AR011126A1 (es) * 1997-02-14 2000-08-02 Smithkline Beecham Corp Procedimiento para preparar eprosartano y compuestos intermediarios.

Also Published As

Publication number Publication date
IL143785A0 (en) 2002-04-21
EG23780A (en) 2007-08-13
ATE274511T1 (de) 2004-09-15
BR9808642A (pt) 2000-05-23
CA2281471A1 (en) 1998-08-20
TR199901935T2 (xx) 1999-12-21
PL335074A1 (en) 2000-04-10
CO4950549A1 (es) 2000-09-01
OA11086A (en) 2003-03-13
JP4227671B2 (ja) 2009-02-18
AP9901619A0 (en) 1999-09-30
CA2281471C (en) 2007-04-24
SK108699A3 (en) 2000-05-16
US20020028951A1 (en) 2002-03-07
NZ337182A (en) 2001-04-27
SK285125B6 (sk) 2006-06-01
CZ285199A3 (cs) 2000-02-16
US6294675B1 (en) 2001-09-25
HUP0001813A3 (en) 2001-07-30
BG103649A (en) 2000-06-30
EP0973769A4 (en) 2001-01-24
NO317761B1 (no) 2004-12-13
DK0973769T3 (da) 2004-12-13
CZ296543B6 (cs) 2006-04-12
HK1026206A1 (en) 2000-12-08
SA98190146B1 (ar) 2006-08-20
BRPI9808642B8 (pt) 2021-05-25
IL143783A0 (en) 2002-04-21
EA001761B1 (ru) 2001-08-27
EA199900741A1 (ru) 2000-02-28
DE69825880D1 (de) 2004-09-30
HUP0001813A2 (hu) 2001-06-28
ES2224358T3 (es) 2005-03-01
BG63970B1 (bg) 2003-08-29
ZA981208B (en) 1998-11-12
CN1247538A (zh) 2000-03-15
IL131310A (en) 2003-02-12
IL143785A (en) 2004-12-15
JP2001511808A (ja) 2001-08-14
IL143784A (en) 2005-05-17
HU228098B1 (en) 2012-10-29
AP1202A (en) 2003-09-02
EP0973769B1 (en) 2004-08-25
MY120024A (en) 2005-08-30
PT973769E (pt) 2004-11-30
IN188000B (xx) 2002-08-03
PE59799A1 (es) 1999-08-06
DZ2418A1 (fr) 2003-06-26
KR100551667B1 (ko) 2006-02-13
CN1093128C (zh) 2002-10-23
MA24472A1 (fr) 1998-10-01
IL143784A0 (en) 2002-04-21
NO993912L (no) 1999-08-13
EP0973769A1 (en) 2000-01-26
CY2551B1 (en) 2008-07-02
ID23155A (id) 2000-03-23
AR011126A1 (es) 2000-08-02
KR20000071008A (ko) 2000-11-25
PL192837B1 (pl) 2006-12-29
BR9808642B1 (pt) 2013-11-26
DE69825880T2 (de) 2005-09-08
AU730162B2 (en) 2001-03-01
IL131310A0 (en) 2001-01-28
WO1998035962A1 (en) 1998-08-20
SI0973769T1 (en) 2004-12-31
UA57060C2 (uk) 2003-06-16
US6458963B1 (en) 2002-10-01
AU6273298A (en) 1998-09-08
NO993912D0 (no) 1999-08-13

Similar Documents

Publication Publication Date Title
HK1071139A1 (en) Intermediate compounds for the preparation of imidazo-pyridine-derivatives
ZA9810059B (en) Method for the preparation of citalopram
PL346237A1 (en) Sethod for the preparation of citalopram
IL132532A (en) Intermediates for the preparation of substituted cephalosporins
IL129906A0 (en) Process for the preparation of beta-isophorone
IL143783A (en) Intermediates for the preparation of eprosartan
IL133140A0 (en) Novel process for the preparation of 4-aryl-piperidines
AP9901626A0 (en) Process for the preparation of substituted thiazolidinedione
EG22402A (en) Oxime compounds their use and intermediates for their production
HUP9903751A3 (en) Intermediates for the preparation of 2-imidazoline-5-ones
HUP0003452A3 (en) Process for the preparation of 1-aryl-3-cyclopropyl-1,3-propanediones
ZA982255B (en) Process for the preparation of arylmalonates.
ZA987741B (en) Process for the preparation of oxazaphosphorine-2-amines
AU7752698A (en) Method for the synthesis of anti-microbial hydroxybenzoats
HUP0001757A3 (en) Improved process for the preparation of halo-4-phenoxyquinolines
ZA989241B (en) Process for the preparation of azacycloalkylalkanoyl pseudotetrapeptides
HUP9902745A2 (en) Process for the preparation of benzylcarbazate
EP1038579A4 (en) PROCESS FOR THE PREPARATION OF CATALYSTS
GB9807032D0 (en) Process for the preparation of (S)-3-carbethoxy-3-benzylpiperidine
IL124387A0 (en) Preparation of 5-Methyleneoxazolines
IL132237A (en) Process for the preparation of 3-isochromanone
GB2329384B (en) Preparation of 1-chloro-1-cyclopropylethene
AU6887198A (en) Improved method for the preparation of benzyluracils
ZA981924B (en) Process for the preparation of n-carboxylalkyl-3-fluoro-4- dialkylaminoanilines
HU0900221D0 (en) Intermediates for the preparation of 3-deoxy-oligosaccharides

Legal Events

Date Code Title Description
KB Patent renewed
KB Patent renewed
KB Patent renewed
EXP Patent expired